Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer. [electronic resource]
Producer: 20100617Description: 395-6 p. digitalISSN:- 1651-226X
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bevacizumab
- Camptothecin -- administration & dosage
- Capecitabine
- Colorectal Neoplasms -- drug therapy
- Deoxycytidine -- administration & dosage
- Drug Administration Schedule
- Feasibility Studies
- Fluorouracil -- administration & dosage
- Humans
- Infusions, Intravenous
- Leucovorin -- administration & dosage
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Retrospective Studies
- Survival Analysis
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.